A comprehensive survey of C. elegans argonaute proteins reveals organism-wide gene regulatory networks and functions

7 figures, 1 table and 9 additional files

Figures

Figure 1 with 2 supplements
Functional validations of GFP::3xFLAG and 3xFLAG tagged Argonautes.

(A) Maximum likelihood evolutionary tree of A. thaliana AGO1 (AtAGO1), D. melanogaster PIWI (DmPIWI), and C. elegans Argonautes. (B) Workflow for characterizing C. elegans Argonautes. (C) Functional …

Figure 1—figure supplement 1
Epitope tag locations and Western blot validations.

(A) Gene diagrams of each Argonaute. The green arrow points to the GFP::3xFLAG tag insertion site. The number corresponds to the distance in amino acids from the first methionine. The letter …

Figure 1—figure supplement 1—source data 1

This file contains original western blots of AGO IPs used in creating Figure 1—figure supplement 1.

https://cdn.elifesciences.org/articles/83853/elife-83853-fig1-figsupp1-data1-v2.zip
Figure 1—figure supplement 2
Additional analyses of tagged Argonautes.

(A) Gene diagrams of WAGO-5 and WAGO-11 as in Figure 1—figure supplement 1 (left). GFP driven under the promoter of WAGO-11 (right). GFP is observed in the distal gonadal sheath of L4 …

Figure 1—figure supplement 2—source data 1

This file contains original western blots of AGO IPs used in creating Figure 1—figure supplement 2.

https://cdn.elifesciences.org/articles/83853/elife-83853-fig1-figsupp2-data1-v2.zip
Argonautes associate with different types of sRNAs and target different categories of genetic features.

(A) 5′ nucleotide and length of sRNAs present in each Argonaute IP shown in bar graph form. The pie charts depict which type of genetic element (biotype) the sRNAs correspond to, as listed. AS = …

Analysis of miRNAs in AGO IPs and ago mutants reveals novel miRNAs.

(A) Clustering diagram of miRNAs enriched in AGOs. Each blue line represents an individual mature miRNA sequence. miRNAs are categorized by conservation, with those conserved to C. briggsae

Figure 3—source data 1

This file contains original western blots of AGO IPs used in creating Figure 3.

https://cdn.elifesciences.org/articles/83853/elife-83853-fig3-data1-v2.zip
Analysis of piRNAs in AGO IPs and ago mutants reveals new piRNAs.

(A) Genomic loci of annotated miRNAs that are enriched in PRG-1 IPs and suspected to be piRNAs. Ruby motifs highlighted above. (B) Violin plots depicting the fold change of all detected piRNAs in ago

Figure 5 with 3 supplements
Analysis of endo-siRNA binding AGOs reveals functional categorization of AGOs to regulate distinct genetic elements.

(A) Clustering diagram of AGO protein-coding gene targets. Each blue line represents a transcript for which endo-sRNAs were enriched twofold or more relative to input in both IPs. 22G-RNAs (defined …

Figure 5—figure supplement 1
Metagene analysis of sRNAs.

Metagene profiles for the protein-coding gene targeting sRNAs enriched in association with each AGO. The number of targets is indicated in parenthesis. To account for differences in the size of …

Figure 5—figure supplement 2
Additional analysis of the endo-siRNA binding AGO IPs.

(A) A Venn diagram showing the overlaps of pseudogene targets of the AGO clusters as highlighted by the color scheme in Figure 5A. (B) A Venn diagram showing the overlaps of transposon targets of …

Figure 5—figure supplement 3
Loss of ago genes results in differential effects of sRNA levels associated with each AGO.

Box plots showing the expression levels (y-axis) of the sRNAs that target the protein-coding targets for which sRNAs were enriched in each AGO IP (x-axis) in the indicated argonaute mutant (panels). …

Figure 6 with 2 supplements
AGOs are differentially expressed in the germline and differentially regulate germline gene expression to promote fertility.

(A) Expression patterns of germline AGOs in L4 (left) and adult (right) germlines. Inset image zoomed in at an individual germ cell nucleus. Yellow arrow points to sperm within the spermatheca. …

Figure 6—figure supplement 1
Additional analysis of AGO mRNA expression.

(A) mRNA levels of AGOs in different developmental stages. Data is an aggregate of public datasets available on WormBase version WS273. (B) Illustration of hermaphrodite germline with sections that …

Figure 6—figure supplement 2
The mortal germline of wago mutants is reversible and associated with reduced germline proliferation.

(A) A temperature shift experiment where wago mutants were placed at 20°C for one generation, then transferred to 25°C for three generations and then back to 20°C. Brood size was measured every …

Figure 7 with 8 supplements
AGOs are expressed in multiple somatic tissues and several are required for normal immunity towards pathogens.

(A) AGOs expressed in the intestine. Adult worms shown. Brackets indicate the type of sRNA AGOs associate with. Intestines are outlined in yellow. Arrowhead indicates intestine cell nuclei. Scale …

Figure 7—figure supplement 1
AGO expression in embryos.

Images of embryos from left to right: 2 cell stage, 4 cell stage, ~40 cell stage, ~200 cell stage (end of gastrulation), comma/bean elongation stage, threefold stage/pretzel stage. Scale bar = 50 µm.

Figure 7—figure supplement 2
AGO expression in L1 larvae.

Images of L1 larvae. Scale bar = 50 µm.

Figure 7—figure supplement 3
AGO expression in L2 larvae.

Images of L2 larvae. Scale bar = 50 µm.

Figure 7—figure supplement 4
AGO expression in L3 larvae.

Images of L3 larvae. Scale bar = 50 µm.

Figure 7—figure supplement 5
AGO expression in L4 larvae.

Images of L4 larvae. Scale bar = 50 µm.

Figure 7—figure supplement 6
AGO expression in adult worms.

Images of adult worms. Scale bar = 50 µm.

Figure 7—figure supplement 7
AGO expression in males.

Images of adult males. Scale bar = 50 µm.

Figure 7—figure supplement 8
Representative images of developmental stages of the RDE-1 transcriptional reporter.

Top row of each panel is DIC + GFP images; bottom row is GFP images shown in grayscale. (A) embryos, (B) L1, (C) L2, (D) L3, (E) L4, and (F) adult. Scale bar = 50 µm. Note that nuclear localization …

Tables

Appendix 1—key resources table
Reagent type (species) or resourceDesignationSource or referenceIdentifiersAdditional information
gene
(C. elegans)
rde-1WormBaseWBGene00004323
gene
(C. elegans)
alg-1WormBaseWBGene00000105
gene
(C. elegans)
alg-2WormBaseWBGene00000106
gene
(C. elegans)
alg-3WormBaseWBGene00011910
gene
(C. elegans)
alg-4WormBaseWBGene00006449
gene
(C. elegans)
alg-5WormBaseWBGene00011945
gene
(C. elegans)
wago-1WormBaseWBGene00011061
gene
(C. elegans)
wago-3/ppw-1WormBaseWBGene00004094
gene
(C. elegans)
wago-4WormBaseWBGene00010263
gene
(C. elegans)
wago-5WormBaseWBGene00022877
gene
(C. elegans)
wago-6/sago-2WormBaseWBGene00018921
gene
(C. elegans)
wago-7/ppw-1WormBaseWBGene00004093
gene
(C. elegans)
wago-8/sago-1WormBaseWBGene00019666
gene
(C. elegans)
wago-9/hrde-1WormBaseWBGene00007624
gene
(C. elegans)
wago-10WormBaseWBGene00020707
gene
(C. elegans)
wago-11WormBaseWBGene00021711
gene
(C. elegans)
wago-12/nrde-3WormBaseWBGene00019862
gene
(C. elegans)
csr-1WormBaseWBGene00017641
gene
(C. elegans)
C04F12.1/vsra-1WormBaseWBGene00007297
strain, strain background (C. elegans; hermaprhodites and males)Bristol N2WormBase
strain, strain background (E. coli)OP50Caenorhabditis Genetics Center
strain, strain background (E. coli)HT115Caenorhabditis Genetics Centers
genetic reagent (C. elegans)List of strainsThis study, Supplementary file 8; Caenorhabditis Genetics Center
antibodyAnti-mouse IgG, HRP-linked Antibody (horse polyclonal)Cell Signaling Technology7076 S1:1000 for western blots
antibodyMonoclonal ANTI-FLAG M2 antibody (mouse monoclonal)SigmaF18041:2000 for western blots 5 μg per 50 μl of Dynabeads in 200 μl for IPs
antibodyGFP-Trap_MA (alpaca recombinant nanobody)ChromoTekgtma20 μl of beads per 5 mg total protein in 500 μl
antibodyRFP-Trap_MA (alpaca recombinant nanobody)ChromoTekrtma20 μl of beads per 5 mg total protein in 500 μl
sequence-based reagentList of oligonucleotidesThis study, Supplementary file 8
sequence-based reagentHigh Throughput Sequencing Data (Conine et al., 2010)https://www.ncbi.nlm.nih.gov/geo/GSE18731
sequence-based reagentHigh Throughput Sequencing Data (Vasale et al., 2010)https://www.ncbi.nlm.nih.gov/geo/GSE18714
sequence-based reagentHigh Throughput Sequencing Data (Claycomb et al., 2009)https://www.ncbi.nlm.nih.gov/geo/GSE18165
sequence-based reagentHigh Throughput Sequencing Data (Gu et al., 2009)https://www.ncbi.nlm.nih.gov/geo/GSE18215
sequence-based reagentHigh Throughput Sequencing Data (Sapetschnig et al., 2015)https://www.ncbi.nlm.nih.gov/geo/GSE66344
sequence-based reagentHigh Throughput Sequencing DataPhillips et al., 2012Table S3
sequence-based reagentHigh Throughput Sequencing DataOrtiz et al., 2014Table S1
sequence-based reagentHigh Throughput Sequencing DataTzur et al., 2018Table S3
sequence-based reagentHigh Throughput Sequencing DataThis study; https://www.ncbi.nlm.nih.gov/geo/GSE208702
commercial assay or kitNEBuilder HiFi DNA Assembly Cloning KitNew England BiolabsE5520
commercial assay or kitNEBNext Multiplex Small RNA Library Prep Kit for IlluminaNew England BiolabsE7560
chemical compound, drugQ5 High-Fidelity DNA PolymeraseNew England BiolabsM0491
chemical compound, drugT4 DNA LigaseNew England BiolabsM0202
chemical compound, drugTri ReagentMolecular Research CentreTR118
chemical compound, drugPhenol Chloroform Isoamyl AlcoholSigma-AldrichP2069
chemical compound, drugcOmplete, Mini, EDTA-free Protease Inhibitor CocktailRoche11836170001
chemical compound, drugRNA 5' PolyphosphataseEpicentreRP8092H
chemical compound, drugPhosphatase Inhibitor Cocktail 2Sigma-AldrichP5726
chemical compound, drugPhosphatase Inhibitor Cocktail 3Sigma-AldrichP0044
chemical compound, drugDTTBioShop CanadaDTT001
chemical compound, drugNP-40BioBasicNDB0385-500ML
chemical compound, drugLevamisole hydrochlorideFisher ScientificAC187870100
chemical compound, drugBovine Serum AlbuminBioBasic9048-46-8
chemical compound, drugSUPERase• In RNase InhibitorThermoFisher Scientific/InvitrogenAM2696
chemical compound, drugT4 Polynucleotide KinaseNew England BiolabsM0201
chemical compound, drugGlycogenAmbionAM9510
chemical compound, drugRNAse and DNAse AwayBioBasicDB0339
chemical compound, drugDynabeads Protein GThermoFisher Scientific/Invitrogen10003D
chemical compound, drugGB-Magic Protein A/G Immunprecipitation Magnetic BeadsGeneBiosystems22202B
chemical compound, drugProtein Assay Reagent ABio-Rad5000113
chemical compound, drugProtein Assay Reagent BBio-Rad5000114
chemical compound, drugProtein Assay Reagent SBio-Rad5000115
chemical compound, drugNitrocellulose blotting membraneGE Healthcare10600016
chemical compound, drugLuminata Classico Western HRP substrateMilliporeWBLUC0500
chemical compound, drugRNase IThermoFisher Scientific/AmbionAM2295
software, algorithmMEGA Xhttps://www.megasoftware.net/
software, algorithmCRISPORhttp://crispor.tefor.net/
software, algorithmSnapGenehttps://www.snapgene.com/
software, algorithmGraphPad Prismhttps://www.graphpad.com/scientific-software/prism/
software, algorithmSTARDobin et al., 2013
software, algorithmRstudiohttps://www.rstudio.com/
software, algorithmCustom Computational Pipelinehttps://github.com/https://github.com/ClaycombLab/Seroussi_2022
otherBolt Precast Bis-Tris Plus Gradient Gels (4–12%)ThermoFisher ScientificNW04120BOXThis study: Materials and Methods
otherHybond C MembraneGE/Amersham BiosciencesCA95038-380LThis study: Materials and Methods
otherWheaton Steel Dounce HomogenizerVWR62400–675This study: Materials and Methods

Additional files

Supplementary file 1

A table summarizing previously published data on C. elegans AGOs.

https://cdn.elifesciences.org/articles/83853/elife-83853-supp1-v2.xlsx
Supplementary file 2

A table summarizing small RNA library information.

https://cdn.elifesciences.org/articles/83853/elife-83853-supp2-v2.xlsx
Supplementary file 3

Tables summarizing the enrichment of reads, biotypes, and AGO targets in all libraries.

https://cdn.elifesciences.org/articles/83853/elife-83853-supp3-v2.xlsb
Supplementary file 4

A table summarizing sRNAs depleted in ago mutants.

https://cdn.elifesciences.org/articles/83853/elife-83853-supp4-v2.xlsx
Supplementary file 5

A table summarizing the mirDeep2 analysis results in predicting novel high confidence miRNAs.

https://cdn.elifesciences.org/articles/83853/elife-83853-supp5-v2.xlsx
Supplementary file 6

A table summarizing the 466 unannotated 21U sRNA sequences enriched in PRG-1 IPs and depleted in prg-1 mutants.

https://cdn.elifesciences.org/articles/83853/elife-83853-supp6-v2.xlsx
Supplementary file 7

Gene Ontology analysis results of AGO targets.

https://cdn.elifesciences.org/articles/83853/elife-83853-supp7-v2.xlsx
Supplementary file 8

Strains and primers used in this study.

https://cdn.elifesciences.org/articles/83853/elife-83853-supp8-v2.xlsx
MDAR checklist
https://cdn.elifesciences.org/articles/83853/elife-83853-mdarchecklist1-v2.pdf

Download links